On this episode host Jonathan Chance talks with Dr. Munir Ghesani, who is a Nuclear Oncologist and the Chief Medical Officer for United Theranostics about (RPT) radiopharmaceutical therapy, which is a treatment for prostate cancer. During the podcast Jonathan and Dr. Ghesani talk about:

·       What is Theranostics and which prostate cancer patients is are candidates for radiopharmaceuticals.

·       How is the therapy administered and how the effectiveness is determined.

·       Are there side effects and how does it compare to alpha emitter radiation therapy.

·       Plutvicto treatment for metastatic prostate cancer.

·       The Vision and PSMA Fore trials of targeted radioligand therapy in patients with prostate cancer.

·       What the future looks like for cancer treatment.

Prostate Cancer Aware is a copyrighted production. No content maybe rebroadcast or reproduced without the expressed written consent of the Friedman Sidrow Foundation. For more information about prostate cancer, the PSA test, men's health and Jonathan's inspiring new book Unaware, which is about his battle with prostate cancer.

• Visit our website at: https://www.iknowmypsa.org
• Email us at: https://www.iknowmypsa.org/contactus/

Follow Prostate Cancer Aware on social media at:

• Facebook - https://www.facebook.com/iknowmypsa
• Twitter - https://twitter.com/iknowmypsa or @iknowmypsa

Thank you for listening! Remember, Stay Aware and Stay Healthy.™